Welcome to our latest healthcare, digital health and life sciences bulletin, which addresses key legal and regulatory issues and evolving areas of law affecting healthcare, digital health and/or life sciences businesses.
In this quarter, we outline NHS England’s £102 million Primary Care Utilisation and Modernisation Fund (UMF) and its impact on GP practices nationwide, and explore Community Diagnostic Centres and available funding for developers. We also offer expert insights on reforms, compliance risks, and emerging opportunities, and share key takeaways from our sessions at the HealthInvestor Healthcare Summit.
This article outlines NHS England’s £102 million Primary Care Utilisation and Modernisation Fund (UMF) and what it means for practices across England. It explains the funding process, grant agreement requirements, legal and financial considerations, and key deadlines practices need to meet.
Read more
With the NHS moving to an online–based service from 2027, private sector investment has been announced for establishing Community Diagnostic Centres through re-developing existing buildings and new developments. This article explains what a Community Diagnostic Centre is, funding available for developers and the planning and design requirements.
Read more
In the UK, healthcare and life sciences businesses face ongoing skills shortages - from frontline clinicians and social care workers to specialist scientists driving research and development. Skilled worker immigration helps bridge these gaps, enabling organisations to access global talent and stay competitive. This article explores the impact of corporate transactions on sponsor licences and right-to-work checks, with practical tips to avoid common pitfalls.
Read more
Boards, operators and investors all face rising patient expectations, workforce pressures, regulatory change and funding challenges. Our legal lowdown guide offers expert insights on reforms, compliance risks, and emerging opportunities - from NHS strategy and employment law changes to tech innovation and energy investment.
Read more
At the 2025 HealthInvestor Healthcare Summit in London, healthtech featured its own dedicated stream for the first time, reflecting its growing influence in health and social care and the UK economy. We joined a session with Paul Hemmings of Nelson Advisors, which focused on deal structuring and how factors such as company size, location, and incentives like EIS shape options and compliance. This article summarises the key takeaways from the session.
Read moreAt the recent HealthInvestor Healthcare Summit in London, we joined a discussion which focused on the challenges of raising finance in today’s uncertain economic climate. With global instability, high interest rates, inflation, and UK tax uncertainty, businesses face significant hurdles. Alongside sector experts, the panel explored how health and social care organisations can secure funding in this environment - this article shares the key takeaways.
Read our key takeaways
Jocelyn Ormond
Partner and Head of the Healthcare & Life Sciences Sector
+44 (0)7872677082 j.ormond@ashfords.co.uk View more
